Join
Live feed
·
PRReleasevia Quantisnow
AtaiBeckley Inc. logo

AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder

ByQuantisnow·Wall Street's wire, on your screen.
ATAI· AtaiBeckley Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATAI (AtaiBeckley Inc.) and more on Quantisnow.